Overall, these insights into GBS-mediated manipulation of the PI3K-Akt pathway and its downstream targets in infected macrophages may provide new insights for the development of diagnostic and therapeutic tools to combat severe GBS disease. This evidence concerns the gene AKT1 and Guillain-Barre syndrome.